Erratum To: Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients

Molecular Diagnosis and Therapy - United Kingdom
doi 10.1007/s40291-016-0228-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of GGCX Polymorphisms on Warfarin Doserequirements in Atrial Fibrillation Patients

Turkish Journal of Medical Sciences
Medicine
2017English

The Effect of CYP4F2, VKORC1 and CYP2C9 in Influencing Coumarin Dose. A Single Patient Data Meta-Analysis in More Than 15,000 Individuals

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Genetic Polymorphisms in Warfarin and Tacrolimus-Related Genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot Population

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2014English

CYP2C9 Genetic Polymorphisms and Warfarin

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2004English

CYP2C9 Gene Analysis of Some Iranian Hypersensitive Patients to Warfarin

Pakistan Journal of Biological Sciences
AgronomyCrop Science
2009English

CYP2C9 Gene Variants, Drug Dose, and Bleeding Risk in Warfarin-Treated Patients: A HuGEnetâ„¢ Systematic Review and Meta-Analysis

Genetics in Medicine
MedicineGenetics
2005English

Correction: GGCX and VKORC1 Inhibit Osteocalcin Endocrine Functions

Journal of Cell Biology
MedicineCell Biology
2019English

Genome-Wide Association Study of VKORC1 and CYP2C9 on Acenocoumarol Dose, Stroke Recurrence and Intracranial Haemorrhage in Spain

Scientific Reports
Multidisciplinary
2020English

Novel Regulatory Variant Detected on the VKORC1 Haplotype That Is Associated With Warfarin Dose

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy